• No notifications yet.
  • Sign Out
logo image
  • logo image
Registered User? Login
Forgot Password?
Sign Up
loader image
New User? Sign Up
Forgot Password?
Login
loader image
    Cocktails and Conversation with Arthur D. Little at the 42nd J.P. Morgan Healthcare Conference logo

    Cocktails and Conversation with Arthur D. Little at the 42nd J.P. Morgan Healthcare Conference

    January 9th, 2024
    6:00 - 9:00 p.m. PST
    Cocktails and Conversations with Arthur D. Little at the 42nd J.P. Morgan Healthcare Conference
    Registration Closed

    RELAX, MIX WITH COLLEAGUES, AND ENJOY COCKTAILS ON US

    Join Arthur D. Little's healthcare and life sciences experts for an evening of informal conversations about combination products, clinical trial assurance and acceleration and development of new drug modalities. You'll enjoy a locally sourced, sustainable farmed organic menu designed by Chef Michele Ledoux, and cocktails featuring an extensive collection of spirits, craft beers and California wines.

    The event will take place in a central location conveniently close to the J.P. Morgan conference. The venue information will be shared once your event registration is confirmed.

    0
    0
    0
    0
    Days
    Hours
    Minutes
    Seconds

    ARTHUR D. LITTLE’S HEALTHCARE AND LIFE SCIENCES TEAM

    speaker image
    CW
    Craig Wylie
    Managing Partner
    Head of Arthur D. Little USA
    speaker image
    US
    Ulrica Sehlstedt
    Managing Partner Board of directors Global Practice Leader, Healthcare & Life Sciences
    Arthur D. Little
    speaker image
    BE
    Ben Enejo
    Partner, Healthcare and Life Sciences Practice
    Arthur D. Little USA
    speaker image
    CB
    Catalina Buttz
    Senior Advisor, Healthcare and Life Sciences Practice
    Arthur D. Little USA
    speaker image
    PP
    Prashanth Prasad
    Principal, Healthcare and Life Sciences Practice, Medical Device and Diagnostics Practice Leader
    Arthur D. Little USA
    speaker image
    FT
    Franziska Thomas
    Partner and Head of Healthcare and Life Sciences, Central Europe
    Arthur D. Little
    speaker image
    RH
    Ryo Hanamura
    Partner, Healthcare and Life Sciences Practice
    Arthur D. Little
    speaker image
    ME
    Michael Eiden
    Partner, Global Head of Artificial Intelligence
    Arthur D. Little
    speaker image
    BV
    Ben van der Schaaf
    Partner, Healthcare and Life Sciences Practice
    Arthur D. Little USA

    CONVERSATION AND NETWORKING

    Arthur D. Little’s healthcare and life sciences  experts look forward to talking with you about recent industry trends  and the  impact on  investments, such as:  

    • Succeeding with combination products
    • Accelerating and assuring clinical trials
    • Develop new drug modalities  

    Succeeding with combination products

    Combination products are revolutionizing patient care by merging diverse therapeutic modalities. By incorporating drugs, devices, or biological components, these groundbreaking products can improve efficacy, increase patient compliance, and streamline healthcare delivery for those with complex medical conditions and intricate care requirements. However, the numerous inherent challenges in bringing these products to market have slowed their development, necessitating more active stakeholder engagement for a growth-building ecosystem.  

    Join us and delve into the multidisciplinary nature of these products and discuss the crucial factors for market entry success, such as regulatory expertise, cross-disciplinary collaboration, seamless technology integration, strategic alliances, and well-planned market access strategies.

    Accelerating and assuring clinical trials

    Ensuring the timely completion of clinical trials is of utmost importance to both patients and trial sponsors. Nevertheless, frequent delays often result in significant financial losses, missed revenue opportunities, and lost market potential. Although this issue has persisted for some time, we believe that a new perspective is necessary to identify inventive solutions and data-based interventions that pinpoint the most effective strategies for addressing clinical trial obstacles, such as locating suitable sites and recruiting and retaining patients.   

    Join us to learn about our work in accelerating clinical trials, even in complex and rare disease areas with novel therapeutics. 

    Developing new drug modalities  

    Innovative drug modalities such as biologics and gene therapies have shifted the traditional small molecule drug development landscape. While holding promise for patients and companies, these therapeutics pose multifaceted challenges.  

    Join us as we navigate development risks, address upfront investment requirements, explore the reevaluation of clinical trial methodologies, delve into emerging regulatory issues, and examine new pricing and reimbursement models. 

    We invite you to a lively discussion around these transformative drug modalities with our team of experts and global industry leaders. Join us as we collectively address challenges and chart a course toward the future of pharmaceutical innovation. 

    VIEWPOINTS FROM ARTHUR D. LITTLE HEALTHCARE & LIFE SCIENCES

    Read Arthur D. Little’s recent report on current and future transformation in healthcare, and the effect these far-reaching changes will have on the life sciences and insurance sectors.

    Read More

    Read Arthur D. Littles perspective of the new speed of innovation in the healthcare area, recently showcased during the recent successful rapid development and rollout of multiple COVID-19 vaccines.

    Read More

    While safety and efficacy are fundamental in drug research, read Arthur D. Littles view on how innovative companies can excel by focusing on pharmacovigilance as a strategic advantage.

    Read More

    STILL HAVE QUESTIONS? GET IN TOUCH

    <div style="text-align: center; font-size:22px"> Form submitted. Thank you! </div>


Looking for your ticket? Contact the organizer
Looking for your ticket? Contact the organizer